KMT2A and leukemia: These include CNVs altering MYC non-coding regulatory regions and specifically, our data implicate a region syntenic to the murine Myc enhancer cluster that has recently been reported to be essential for the maintenance of MLL–AF9-driven leukemia in mice [32].